Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab.
Marloes E van MuijenSelma AtalayL J van VugtL M D VandermaesenJuul M P A van den ReekElke M G J de JongPublished in: Drugs - real world outcomes (2021)
Psoriasis patients with controlled disease still report substantial treatment needs, with high importance ascribed to confidence in healing. To apply personalized medicine, treatment needs should be explored on an individual level.